Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 11:47 am Sale | 2023-12-31 | 13G | ADMA BIOLOGICS INC ADMA | TEACHERS ADVISORS LLC | 5,062,545 2.240% | -420,824 (-7.67%) | Filing History |
| 2024-02-14 11:37 am Sale | 2023-12-31 | 13G | ADMA BIOLOGICS INC ADMA | TIAA CREF INVESTMENT MANAGEMENT LLC | 5,062,545 2.240% | -420,824 (-7.67%) | Filing History |
| 2024-02-13 4:56 pm Purchase | 2023-12-29 | 13G | ADMA BIOLOGICS INC ADMA | VANGUARD GROUP INC | 12,891,875 5.710% | 12,891,875 (New Position) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | ADMA BIOLOGICS INC ADMA | BlackRock Inc. BLK | 17,917,745 7.900% | 2,816,464 (+18.65%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | Perceptive Advisors LLC | 11,900,255 5.400% | -33,132 (-0.28%) | Filing History |
| 2023-02-14 08:50 am Purchase | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | Nuveen Asset Management LLC | 5,483,369 2.480% | 5,483,369 (New Position) | Filing History |
| 2023-02-14 08:48 am Purchase | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | TEACHERS ADVISORS LLC | 5,483,369 2.480% | 5,483,369 (New Position) | Filing History |
| 2023-02-14 08:47 am Purchase | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | TIAA CREF INVESTMENT MANAGEMENT LLC | 5,483,369 2.480% | 5,483,369 (New Position) | Filing History |
| 2023-02-13 10:55 am Sale | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | Stonepine Capital Management, LLC | 6,940,000 3.100% | -2,971,577 (-29.98%) | Filing History |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | ADMA BIOLOGICS INC ADMA | BlackRock Inc. BLK | 15,101,281 6.900% | 9,347,461 (+162.46%) | Filing History |
| 2022-12-09 5:00 pm Sale | 2022-12-09 | 13D | ADMA BIOLOGICS INC ADMA | Caligan Partners LP | 10,264,311 4.600% | -628,926 (-5.77%) | Filing History |
| 2022-06-28 4:38 pm Purchase | 2022-06-21 | 13G | ADMA BIOLOGICS INC ADMA | Millennium Management LLC | 6,254,409 3.200% | 6,254,409 (New Position) | Filing History |
| 2022-02-14 8:55 pm Unchanged | 2021-12-31 | 13G | ADMA BIOLOGICS INC ADMA | Perceptive Advisors LLC | 11,933,387 6.100% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:52 pm Unchanged | 2020-12-31 | 13G | ADMA BIOLOGICS INC ADMA | Consonance Capital Management LP | 1,558,290 1.650% | 0 (Unchanged) | Filing History |
| 2022-02-14 08:21 am Sale | 2021-12-31 | 13G | ADMA BIOLOGICS INC ADMA | Stonepine Capital Management, LLC | 9,911,577 5.100% | -61,300 (-0.61%) | Filing History |
| 2022-02-11 2:39 pm Purchase | 2021-12-31 | 13G | ADMA BIOLOGICS INC ADMA | NWQ INVESTMENT MANAGEMENT COMPANY LLC | 10,612,600 5.420% | 10,612,600 (New Position) | Filing History |
| 2022-02-04 08:30 am Purchase | 2022-02-03 | 13D | ADMA BIOLOGICS INC ADMA | Caligan Partners LP | 10,893,237 5.600% | 10,893,237 (New Position) | Filing History |
| 2021-12-30 12:26 pm Purchase | 2021-12-28 | 13G | ADMA BIOLOGICS INC ADMA | Stonepine Capital Management, LLC | 9,972,877 5.100% | 9,972,877 (New Position) | Filing History |
| 2021-10-27 09:16 am Sale | 2021-10-22 | 13G | ADMA BIOLOGICS INC ADMA | Perceptive Advisors LLC | 11,933,387 6.600% | -4,651,415 (-28.05%) | Filing History |